Vistagen Therapeutics, Inc. (VTGN)
0.5968
+0.01
(+1.84%)
USD |
NASDAQ |
Mar 02, 16:00
0.5947
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics EPS Diluted (Quarterly) : -0.4475 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alector, Inc. | -0.3403 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.90M |
| Revenue (Quarterly) | 0.303M |
| Total Expenses (Quarterly) | 19.20M |
| Enterprise Value | -37.13M |
| Gross Profit Margin (Quarterly) | 37.62% |
| Profit Margin (Quarterly) | -6.24K% |
| Earnings Yield | -322.1% |
| Normalized Earnings Yield | -322.07 |